Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer’s disease

被引：0
|
作者：
Dongmei Chen
Guihua Lan
Ruomeng Li
Yingxue Mei
Xindong Shui
Xi Gu
Long Wang
Tao Zhang
Chen-Ling Gan
Yongfang Xia
Li Hu
Yuan Tian
Mi Zhang
Tae Ho Lee
机构：
[1] Fujian Medical University,Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, School of Basic Medical Sciences
[2] Longyan First Hospital Affiliated to Fujian Medical University,Department of Pathology
来源：
Translational Neurodegeneration | / 11卷
关键词：
Alzheimer’s disease; Melatonin; miR-504-3p; p39; Tau;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Physical Exercise Ameliorates the Cognitive Function and Attenuates the Neuroinflammation of Alzheimer's Disease via miR-129-5p
    Li, Zhen
    Chen, Qi
    Liu, Jinxia
    Du, Yifeng
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2020, 49 (02) : 163 - 169
  • [22] Streptozotocin Induces Alzheimer's Disease-Like Pathology in Hippocampal Neuronal Cells via CDK5/Drp1-Mediated Mitochondrial Fragmentation
    Park, Junghyung
    Won, Jinyoung
    Seo, Jincheol
    Yeo, Hyeon-Gu
    Kim, Keonwoo
    Kim, Yu Gyeong
    Jeon, Chang-Yeop
    Kam, Min Kyoung
    Kim, Young-Hyun
    Huh, Jae-Won
    Lee, Sang-Rae
    Lee, Dong-Seok
    Lee, Youngjeon
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14
  • [23] miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease
    Han, Sang-Won
    Pyun, Jung-Min
    Bice, Paula J.
    Bennett, David A.
    Saykin, Andrew J.
    Kim, Sang Yun
    Park, Young Ho
    Nho, Kwangsik
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [24] p38-MAPK and CDK5,signaling pathways in neuroinflammation:a potential therapeutic intervention in Alzheimer's disease?
    Vlad lonut Viorel
    Ylenia Pastorello
    Nosherwan Bajwa
    Mark Slevin
    [J]. Neural Regeneration Research, 2024, (08) : 1649 - 1650
  • [25] miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s disease
    Sang-Won Han
    Jung-Min Pyun
    Paula J. Bice
    David A. Bennett
    Andrew J. Saykin
    Sang Yun Kim
    Young Ho Park
    Kwangsik Nho
    [J]. Alzheimer's Research & Therapy, 16
  • [26] p38-MAPK and CDK5, signaling pathways in neuroinflammation: a potential therapeutic intervention in Alzheimer's disease?
    Viorel, Vlad Ionut
    Pastorello, Ylenia
    Bajwa, Nosherwan
    Slevin, Mark
    [J]. NEURAL REGENERATION RESEARCH, 2024, 19 (08) : 1649 - 1650
  • [27] MiR-26a-5p promotes Alzheimer's disease by regulating CDK5R1
    Cao, Dujuan
    Shang, Jing
    Ren, Chongren
    [J]. SCIENCEASIA, 2023, 49 (06):
  • [28] Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease
    Zumkehr, Joannee
    Rodriguez-Ortiz, Carlos J.
    Cheng, David
    Kieu, Zanett
    Wai, Thin
    Hawkins, Charlesice
    Kilian, Jason
    Lim, Siok Lam
    Medeiros, Rodrigo
    Kitazawa, Masashi
    [J]. NEUROBIOLOGY OF AGING, 2015, 36 (07) : 2260 - 2271
  • [29] Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology
    Liu, Shan
    Breitbart, Ariel
    Sun, Yanjie
    Mehta, Pankaj D.
    Boutajangout, Allal
    Scholtzova, Henrieta
    Wisniewski, Thomas
    [J]. JOURNAL OF NEUROCHEMISTRY, 2014, 128 (04) : 577 - 591
  • [30] Levels of activators of cyclin-dependent protein kinase 5 (Cdk5) p25 and p35 in Alzheimer's disease
    Engmann, O.
    Hortobagyi, T.
    Thompson, A.
    Giese, K. P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S7 - S8
12345